Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
South Asia: In South Asia, India leads the demand for GLP-1 receptor agonists, supported by a large diabetic patient population and increasing healthcare access
Coverage varies widely because many commercial plans exclude weight-loss medications entirely
The SURMOUNT-1 DXA substudy (Look et al., 2025) showed that tirzepatide reduced lean body mass by 10.9% over 72 weeks, compared to 2.6% with placebo
OTHER INGREDIENTS: Vegetarian Capsule (hypromellose and water), Magnesium Stearate (plant-based), Silicon Dioxide
US$ 21.21
US$ 20.40
US$ 23.94
US$ 27.52
US$ 23.94
